Heck Capital Advisors LLC purchased a new position in shares of The Clorox Company (NYSE:CLX – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 505 shares of the company’s stock, valued at approximately $82,000.
A number of other hedge funds have also recently modified their holdings of the business. Mizuho Securities USA LLC raised its stake in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP increased its stake in shares of Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after purchasing an additional 453,624 shares in the last quarter. International Assets Investment Management LLC increased its stake in shares of Clorox by 424.9% in the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after purchasing an additional 435,971 shares in the last quarter. Boston Trust Walden Corp raised its position in shares of Clorox by 5,442.5% during the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after purchasing an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in Clorox by 302.0% in the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after buying an additional 265,455 shares during the period. Institutional investors own 78.53% of the company’s stock.
Clorox Trading Down 1.2 %
Shares of NYSE CLX opened at $158.60 on Monday. The stock has a market capitalization of $19.63 billion, a P/E ratio of 55.26, a PEG ratio of 2.91 and a beta of 0.42. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The business’s 50 day moving average is $162.76 and its two-hundred day moving average is $158.35. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.
Clorox Dividend Announcement
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the company. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Barclays lowered their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday. DA Davidson upped their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $156.07.
View Our Latest Analysis on Clorox
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- How to Calculate Options Profits
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- How to Effectively Use the MarketBeat Ratings Screener
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.